This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
April 2, 2013 /PRNewswire-USNewswire/ -- The Alzheimer's Foundation of America (AFA), a leading national nonprofit organization dedicated to optimal care for people with Alzheimer's disease and their families, today applauded President Obama's announcement to invest
$100 million in ground-breaking research that will map the human brain. The "BRAIN" (Brain Research Through Advancing Innovative Neurotechnologies) Initiative, an idea that the President first noted in his State of the Union address earlier this year, is aimed at uncovering new ways to treat, prevent, and cure brain disorders such as Alzheimer's disease and traumatic brain injury.
Carol Steinberg, acting chief executive officer of the Alzheimer's Foundation of America:
"The Alzheimer's Foundation of America applauds President Obama for committing substantial research dollars toward the better understanding the human brain and for his continuing recognition of the public health crisis posed by Alzheimer's disease.
"The BRAIN Initiative is an exciting development and a potential game changer in unlocking the mysteries of Alzheimer's disease. This far-reaching project holds the promise of providing deeper insights into concepts such as cognitive reserve, ultimately leading to ways to treat or even prevent Alzheimer's disease. It is just the shot in the arm that both scientists and families need right now, especially in light of flat research funding for Alzheimer's disease and the threat of this devastating disease overwhelming more and more Americans.
"AFA's hope is that funding for the BRAIN Initiative is the start of a pipeline of stepped-up funding for other research toward an effective treatment and cure of Alzheimer's disease as well as for care-related support services for individuals with the disease and their caregivers. In addition to investing in larger initiatives that have the potential for big payoffs in the future, we need to continue to fund research farther along in the drug development process so that families can embrace treatment and prevention in their lifetimes.